Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| NCI-2015-00097 | Registry Identifier | CTRP (Clinical Trial Reporting Program) | |
| CCCWFU 02114 | Other Identifier | Comprehensive Cancer Center of Wake Forest University | |
| P30CA012197 | U.S. NIH Grant/Contract | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| National Cancer Institute (NCI) | NIH |
Not provided
Not provided
Not provided
Not provided
This pilot clinical trial studies how well consumer-based activity monitor works in evaluating and measuring activity of older patients with abdominal cancer undergoing surgery. Consumer-based activity monitor (CAM) may identify patients who are at-risk for increased post-surgery medical problems. With early identification of at-risk patients, CAM provide supervised exercise in the preoperative and postoperative periods to improve over mobility and potentially decrease preoperative complications among patients undergoing major abdominal surgery.
PRIMARY OBJECTIVES:
I. To demonstrate the feasibility and adherence of using a consumer-based activity monitor during the preoperative period both in the hospital as well as at home.
SECONDARY OBJECTIVES:
I. To evaluate the ability of a consumer-based activity monitor to demonstrate a 50% decrease in average daily steps for participants before and after major oncologic surgery.
II. To characterize in-home movement among older cancer patients. III. To compare in-home CAM data to in-clinic pre- and post-operative mobility testing using the Short Physical Performance Battery (SPPB).
IV. To compare in-home CAM data to pre- and post-operative self-reported mobility using the Pepper Assessment Tool for Disability (PAT-D) and the Mobility Assessment Tool-Short Form (MAT-sf).
V. To compare in-home CAM data to self-reported daily activity data during the pre- and post-operative period.
VI. To determine estimates of future study accrual, adherence, and drop-out. VII. To obtain participant feedback from participants to determine potential study opportunities and barriers.
VIII. To identify potential key stakeholders and potential patient partners for development of future grant submissions.
IX. To summarize baseline cognitive screens, physical assessment questionnaire (Pepper Assessment Tool for Disability, PAT-D), mobility assessment tool-short form (MAT-sf), health-related quality of life (FACIT-G) questionnaire, activity questionnaire (Community Healthy Activities Model Program for Seniors [CHAMPS]), pain assessment (Pain Visual Analog Scale, PVAS), fatigue assessment (Fatigue Visual Analog Scale, FVAS), and physical function testing (Short Physical Performance Battery and time to complete 400-meter walk).
X. CAM data will be compared with research grade activity data provided by the ActiGraph.
OUTLINE:
Patients wear Fitbit Zip (portable pedometer device) to track physical activity for 7 days before undergoing surgery and for 21 more days after undergoing surgery.
After completion of study, patients are followed up at 21 and 90 days.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Supportive care (consumer-based activity monitor) | Experimental | Patients wear Fitbit Zip (portable pedometer device) to track physical activity for 7 days before undergoing surgery and for 21 more days after undergoing surgery. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Management of Therapy Complications Fitbit Zip (portable pedometer device) | Device | Use pedometer to monitor physical activity |
|
| Measure | Description | Time Frame |
|---|---|---|
| Number of Patients Who Self-report Wearing the Consumer-based Activity Monitor at Least 16 Days of the 21 Day Period | Feasibility will be defined as the number of patients who self-report wearing the CAM device at least 16 days of the 21 day period. | 21 days |
| Measure | Description | Time Frame |
|---|---|---|
| Change in Daily Steps for Participants Before and After Major Oncologic Surgery | This outcome measure will be the change in daily steps for participants before and after major oncologic surgery. Change in median (IQR) steps reported. | baseline and 90 days |
| Change in Short Physical Performance Battery (SPPB) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Clancy Clark | Wake Forest University Health Sciences | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Comprehensive Cancer Center of Wake Forest University | Winston-Salem | North Carolina | 27157 | United States |
Not provided
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| FG000 | Supportive Care (Consumer-based Activity Monitor) | Patients wear Fitbit Zip (portable pedometer device) to track physical activity for 7 days before undergoing surgery and for 21 more days after undergoing surgery. Management of Therapy Complications Fitbit Zip (portable pedometer device): Use pedometer to monitor physical activity Questionnaire Administration: Ancillary studies Quality-of-Life Assessment: Ancillary studies |
| Title | Milestones | Reasons Not Completed | |||||
|---|---|---|---|---|---|---|---|
| Overall Study |
|
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Questionnaire Administration | Other | Ancillary studies |
|
| Quality-of-Life Assessment | Other | Ancillary studies |
|
|
This outcome measure is to compare pre- and post-operative mobility using the Short Physical Performance Battery (SPPB). Median (IQR) change in SPPB from baseline to 90 days is reported.The scale range is 0-16. Higher scores denotes better outcomes. |
| baseline and 90 days |
| Change in Duration of 400-meter Walk | This outcome measure is to compare pre- and post-operative mobility testing using the 400-meter walk. Median (IQR) change in 400 m walk from baseline to 90 days is reported. The duration it takes the participant to walk 400 meters will be recorded in seconds. | baseline and 90 days |
| Change in Pepper Assessment Tool for Disability (PAT-D) | This outcome measure is to compare pre- and post-operative self-reported mobility using the Pepper Assessment Tool for Disability (PAT-D). Median (IQR) change in PAT-D is reported. | baseline and 90 days |
| Change in the Mobility Assessment Tool-Short Form (MAT-sf). | This outcome measure is to compare pre- and post-operative self-reported mobility using the Mobility Assessment Tool-Short Form (MAT-sf). Median (IQR) change in MAT-sf is reported. The score range is 30-80 and higher scores denotes better outcomes. | baseline and 90 days |
| Change in CHAMPS Between the Pre- and Post-operative Period | This outcome measure is to compare self-reported activity data (CHAMPS) during the pre- and post-operative period. Median (IQR) change in CHAMPS is reported. CHAMPS measures activity of the participant and how long they could do the activity. The score range is 0-108. Higher scores denotes better outcomes. | baseline and 90 days |
| Change in Health-related Quality of Life (FACT-G) Questionnaire | FACT-G is a 27-item compilation of general questions divided into 4 primary quality of life (QOL) domains: physical well-being, social/family well-being, emotional well-being, and functional well-being. The subscales are summed to produce a total score. The total score range is 0-108 and a higher score indicates better quality of life. Outcomes is to compare FACT-G at baseline and 90 days. Change in FACT-G is reported in median (IQR). | baseline and 90 days |
| Change in Pain Assessment -Pain Visual Analog Scale, (PVAS) | The pain VAS is a unidimensional measure of pain intensity providing a range of scores from 0-100. A higher score indicates greater pain intensity. Change in median (IQR) pain score from baseline to 90 days is reported. | baseline and 90 days |
| Change in Fatigue Assessment- Fatigue Visual Analog Scale (FVAS). | The fatigue VAS is a unidimensional measure of fatigue providing a range of scores from 0-100. A higher score indicates greater fatigue. Change in median (IQR) fatigue score from baseline to 90 days is reported. | baseline and 90 days |
| COMPLETED |
|
| NOT COMPLETED |
|
Not provided
| ID | Title | Description |
|---|---|---|
| BG000 | Supportive Care (Consumer-based Activity Monitor) | Patients wear Fitbit Zip (portable pedometer device) to track physical activity for 7 days before undergoing surgery and for 21 more days after undergoing surgery. Management of Therapy Complications Fitbit Zip (portable pedometer device): Use pedometer to monitor physical activity Questionnaire Administration: Ancillary studies Quality-of-Life Assessment: Ancillary studies |
| Units | Counts |
|---|---|
| Participants |
|
| Title | Description | Population Description | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Denominator Units Selected | Denominators | Classes | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Age, Categorical | Count of Participants | Participants |
| ||||||||||||||||||||
| Age, Continuous | Mean | Standard Deviation | years |
| |||||||||||||||||||
| Sex: Female, Male | Count of Participants | Participants |
| ||||||||||||||||||||
| Ethnicity (NIH/OMB) | Count of Participants | Participants |
| ||||||||||||||||||||
| Race (NIH/OMB) | Count of Participants | Participants |
| ||||||||||||||||||||
| Region of Enrollment | Count of Participants | Participants |
|
| Type | Title | Description | Population Description | Reporting Status | Anticipated Posting Date | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Time Frame | Units Analyzed | Denominator Units Selected | Arm/Group Information | Denominators | Classes | Analyses | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary | Number of Patients Who Self-report Wearing the Consumer-based Activity Monitor at Least 16 Days of the 21 Day Period | Feasibility will be defined as the number of patients who self-report wearing the CAM device at least 16 days of the 21 day period. | 34 patients enrolled in study. 28 patients had data collected. Due to challenges associated with data collection, partial data was collected for 18 patients. | Posted | Count of Participants | Participants | 21 days |
|
|
| ||||||||||||||||||||||||||
| Secondary | Change in Daily Steps for Participants Before and After Major Oncologic Surgery | This outcome measure will be the change in daily steps for participants before and after major oncologic surgery. Change in median (IQR) steps reported. | 16 subjects had sufficient data for partial analysis. | Posted | Median | Inter-Quartile Range | steps | baseline and 90 days |
|
| ||||||||||||||||||||||||||
| Secondary | Change in Short Physical Performance Battery (SPPB) | This outcome measure is to compare pre- and post-operative mobility using the Short Physical Performance Battery (SPPB). Median (IQR) change in SPPB from baseline to 90 days is reported.The scale range is 0-16. Higher scores denotes better outcomes. | Only 9 subjects had SPPB measured at baseline and 90 days. | Posted | Median | Inter-Quartile Range | units on a scale | baseline and 90 days |
|
| ||||||||||||||||||||||||||
| Secondary | Change in Duration of 400-meter Walk | This outcome measure is to compare pre- and post-operative mobility testing using the 400-meter walk. Median (IQR) change in 400 m walk from baseline to 90 days is reported. The duration it takes the participant to walk 400 meters will be recorded in seconds. | Only 10 subjects had 400m walk measured at baseline and 90 days | Posted | Median | Inter-Quartile Range | seconds | baseline and 90 days |
|
| ||||||||||||||||||||||||||
| Secondary | Change in Pepper Assessment Tool for Disability (PAT-D) | This outcome measure is to compare pre- and post-operative self-reported mobility using the Pepper Assessment Tool for Disability (PAT-D). Median (IQR) change in PAT-D is reported. | Data were not collected and therefore analysis cannot performed. | Posted | baseline and 90 days |
|
| |||||||||||||||||||||||||||||
| Secondary | Change in the Mobility Assessment Tool-Short Form (MAT-sf). | This outcome measure is to compare pre- and post-operative self-reported mobility using the Mobility Assessment Tool-Short Form (MAT-sf). Median (IQR) change in MAT-sf is reported. The score range is 30-80 and higher scores denotes better outcomes. | Only 7 subjects had MAT-sf measured at baseline and 90 days. | Posted | Median | Inter-Quartile Range | units on a scale | baseline and 90 days |
|
| ||||||||||||||||||||||||||
| Secondary | Change in CHAMPS Between the Pre- and Post-operative Period | This outcome measure is to compare self-reported activity data (CHAMPS) during the pre- and post-operative period. Median (IQR) change in CHAMPS is reported. CHAMPS measures activity of the participant and how long they could do the activity. The score range is 0-108. Higher scores denotes better outcomes. | 5 subjects have CHAMPs data at baseline and 90 days. | Posted | Median | Inter-Quartile Range | score on a scale | baseline and 90 days |
|
| ||||||||||||||||||||||||||
| Secondary | Change in Health-related Quality of Life (FACT-G) Questionnaire | FACT-G is a 27-item compilation of general questions divided into 4 primary quality of life (QOL) domains: physical well-being, social/family well-being, emotional well-being, and functional well-being. The subscales are summed to produce a total score. The total score range is 0-108 and a higher score indicates better quality of life. Outcomes is to compare FACT-G at baseline and 90 days. Change in FACT-G is reported in median (IQR). | Only 6 subjects reported FACT-G at baseline and 90 days. | Posted | Median | Inter-Quartile Range | units on a scale | baseline and 90 days |
|
| ||||||||||||||||||||||||||
| Secondary | Change in Pain Assessment -Pain Visual Analog Scale, (PVAS) | The pain VAS is a unidimensional measure of pain intensity providing a range of scores from 0-100. A higher score indicates greater pain intensity. Change in median (IQR) pain score from baseline to 90 days is reported. | Only 6 subjects had pain VAS measured at baseline and 90 days. | Posted | Median | Inter-Quartile Range | units on a scale | baseline and 90 days |
|
| ||||||||||||||||||||||||||
| Secondary | Change in Fatigue Assessment- Fatigue Visual Analog Scale (FVAS). | The fatigue VAS is a unidimensional measure of fatigue providing a range of scores from 0-100. A higher score indicates greater fatigue. Change in median (IQR) fatigue score from baseline to 90 days is reported. | Only 6 subjects reported fatigue VAS at baseline and 90 days. | Posted | Median | Inter-Quartile Range | units on a scale | baseline and 90 days |
|
|
1 year
No adverse events occurred for study. Definitions used for adverse events did not differ from clinicaltrials.gov
Not provided
| ID | Title | Description | Deaths (Affected) | Deaths (At Risk) | Serious Events (Affected) | Serious Events (At Risk) | Other Events (Affected) | Other Events (At Risk) |
|---|---|---|---|---|---|---|---|---|
| EG000 | Supportive Care (Consumer-based Activity Monitor) | Patients wear Fitbit Zip (portable pedometer device) to track physical activity for 7 days before undergoing surgery and for 21 more days after undergoing surgery. Management of Therapy Complications Fitbit Zip (portable pedometer device): Use pedometer to monitor physical activity Questionnaire Administration: Ancillary studies Quality-of-Life Assessment: Ancillary studies | 0 | 28 | 0 | 28 | 0 | 28 |
Not provided
Not provided
This feasibility study closed early due to slow accrual and inability to capture specific study variables. Small sample size limited study analysis and prevents reliable interpretation of data collected.
Not provided
Not provided
Not provided
| Title | Organization | Phone | Extension | |
|---|---|---|---|---|
| Dr. Clancy Clark | Wake Forest University Health Sciences | 336-716-7207 | cjclark@wakehealth.edu |
| ID | Term |
|---|---|
| D005770 | Gastrointestinal Neoplasms |
| ID | Term |
|---|---|
| D004067 | Digestive System Neoplasms |
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
| D004066 | Digestive System Diseases |
| D005767 | Gastrointestinal Diseases |
Not provided
Not provided
| Unknown or Not Reported |
|
| Native Hawaiian or Other Pacific Islander |
|
| Black or African American |
|
| White |
|
| More than one race |
|
| Unknown or Not Reported |
|
|
|
|
|
|
|
|
|